BESIMPTA Trademark

Trademark Overview


On Friday, January 3, 2020, a trademark application was filed for BESIMPTA with the United States Patent and Trademark Office. The USPTO has given the BESIMPTA trademark a serial number of 88746136. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, May 2, 2022. This trademark is owned by Novartis AG. The BESIMPTA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
besimpta

General Information


Serial Number88746136
Word MarkBESIMPTA
Filing DateFriday, January 3, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, May 2, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "BESIMPTA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 4 GRANTED
Monday, May 2, 2022SOU EXTENSION 4 FILED
Monday, May 2, 2022TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2021SOU EXTENSION 3 GRANTED
Monday, November 1, 2021SOU EXTENSION 3 FILED
Monday, November 1, 2021TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021SOU EXTENSION 2 GRANTED
Monday, May 3, 2021SOU EXTENSION 2 FILED
Monday, May 3, 2021TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020SOU EXTENSION 1 GRANTED
Friday, October 30, 2020SOU EXTENSION 1 FILED
Friday, October 30, 2020TEAS EXTENSION RECEIVED
Tuesday, May 5, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 4, 2020ASSIGNED TO EXAMINER
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 7, 2020NEW APPLICATION ENTERED IN TRAM